Orchestra BioMed
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $987 | $778 | $620 | $262 |
Gross Profit | 919 | 734 | 512 | 179 |
EBITDA | -16,266 | -16,785 | -14,349 | -12,409 |
EBIT | -16,342 | -16,859 | -14,423 | -12,481 |
Net Income | -15,426 | -15,980 | -13,463 | -12,818 |
Net Change In Cash | 987 | 778 | 620 | 262 |
Free Cash Flow | -13,768 | -10,313 | -13,122 | -10,971 |
Cash | 25,605 | 23,713 | 23,324 | 30,559 |
Basic Shares | 37,621 | 35,800 | 35,777 | 35,777 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,760 | $3,533 | $-782 | $5,703 |
Gross Profit | 2,574 | 3,211 | -981 | 5,558 |
EBITDA | -51,219 | -32,435 | -21,618 | -18,615 |
EBIT | -51,506 | -32,657 | -21,799 | -18,752 |
Net Income | -49,120 | -33,608 | -23,014 | -21,355 |
Net Change In Cash | 2,760 | 3,533 | -782 | 5,703 |
Free Cash Flow | -46,205 | -29,880 | -19,703 | -26,722 |
Cash | 30,559 | 19,784 | 9,938 | 20,343 |
Basic Shares | 33,225 | 14,988 | 20,450 | 20,450 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.41 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.38 |
2023-12-31 | -$0.37 |
